ATX — Amplia Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00- AU$114.45m
- AU$103.60m
- AU$3.77m
- 30
- 20
- 60
- 31
Annual balance sheet for Amplia Therapeutics, fiscal year end - March 31st, AUD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 1.85 | 14.6 | 9.26 | 3.39 | 10.9 |
| Net Total Receivables | 1 | 1.84 | 1.15 | 3.18 | 3.77 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2.94 | 16.5 | 10.5 | 6.75 | 14.9 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.005 | 0.013 | 0.185 | 0.101 | 0.017 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 10.9 | 24.5 | 18.7 | 14.8 | 22.9 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.539 | 0.53 | 2.75 | 3.4 | 1.89 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.539 | 2.64 | 2.85 | 3.43 | 1.91 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 10.3 | 21.8 | 15.8 | 11.4 | 21 |
| Total Liabilities & Shareholders' Equity | 10.9 | 24.5 | 18.7 | 14.8 | 22.9 |
| Total Common Shares Outstanding |